Philip J. R. Roche
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Philip J. R. Roche has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
Andrew G. Kirk
McGill University
1 shared publication- Bhushan Nagar
Department of Biochemistry, McGill University, Montreal, Quebec, Canada
1 shared publication Bruce R. Lennox
McGill University
1 shared publication- Christopher Jf Cameron
Yale University
1 shared publication - Denis Paquette
Department of Biochemistry and Rosalind & Morris Goodman Cancer Research Center, McGill University, Montréal, Québec, H3G 1Y6, Canada
1 shared publication - Faiz Hussain
McGill University
1 shared publication
Latest Publications
- Open Access
Homology Directed Repair by Cas9:Donor Co-localization in Mammalian Cells
Homology directed repair (HDR) induced by site specific DNA double strand breaks (DSB) with CRISPR/Cas9 is a precision gene editing approach that occurs at low frequency in comparison to indel forming non homologous end joining (NHEJ). In order to obtain high HDR percentages in mammalian cells, we engineered Cas9 protein fused to a high-affinity monoavidin domain to deliver biotinylated donor DNA to a DSB site. In addition, we used the cationic polymer, polyethylenimine, to deliver Cas9 RNP-donor DNA complex into the cell. Combining these strategies improved HDR percentages of up to 90% in three tested loci (CXCR4, EMX1, and TLR) in standard HEK293 cells. Our approach offers a cost effective, simple and broadly applicable gene editing method, thereby expanding the CRISPR/Cas9 genome editing toolbox. Summary: Precision gene editing occurs at a low percentage in mammalian cells using Cas9. Colocalization of donor with Cas9MAV and PEI delivery raises HDR occurrence.
Open AccessHomology Directed Repair by Cas9:Donor Co-localization in Mammalian Cells
Homology directed repair (HDR) induced by site specific DNA double strand breaks (DSB) with CRISPR/Cas9 is a precision gene editing approach that occurs at low frequency in comparison to indel forming non homologous end joining (NHEJ). In order to obtain high HDR percentages in mammalian cells, we engineered Cas9 protein fused to a high-affinity monoavidin domain to deliver biotinylated donor DNA to a DSB site. In addition, we used the cationic polymer, polyethylenimine, to deliver Cas9 RNP-donor DNA complex into the cell. Combining these strategies improved HDR percentages of up to 90% in three tested loci (CXCR4, EMX1, and TLR) in standard HEK293 cells. Our approach offers a cost effective, simple and broadly applicable gene editing method, thereby expanding the CRISPR/Cas9 genome editing toolbox. Summary: Precision gene editing occurs at a low percentage in mammalian cells using Cas9. Colocalization of donor with Cas9MAV and PEI delivery raises HDR occurrence.
- 6 December 2011
- Published by Springer Nature in Plasmonics
- Vol. 7 (2) , 331-339
Characterisation of a Gold Nanorod Sol–Gel Utilising Inter-particle Coupling to Yield High Refractive Index Sensitivity
- 6 December 2011
- Published by Springer Nature in Plasmonics
- Vol. 7 (2) , 331-339
Characterisation of a Gold Nanorod Sol–Gel Utilising Inter-particle Coupling to Yield High Refractive Index Sensitivity